Genomic Health® gives cancer patients and their healthcare providers insight needed to help make quality
treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare
professionals understand how individualized genomic profiling of tumor tissue may help improve
cancer management.
The first diagnostic assay developed by Genomic Health — Oncotype DX® — is a breast cancer test
that may assist treatment planning by quantifying the likelihood of distant breast cancer
recurrence.
To learn more about Oncotype DX patients click here or on the image above.
